Research graph
References from Sustained clinical remission and long-term safety of molnupiravir as first-line therapy for effusive feline infectious peritonitis: a 40-week retrospective study. Local targets link to admitted publications; unresolved targets remain external evidence.
Feline infectious peritonitis. ABCD guidelines on prevention and management
10.1016/j.jfms.2009.05.008 · 2009 · External reference
Comparative evaluation of GS-441524, teriflunomide, ruxolitinib, molnupiravir, ritonavir, and nirmatrelvir for In vitro antiviral activity against feline infectious peritonitis virus
10.3390/vetsci10080513 · 2023 · External reference
Clinical trial of molnupiravir with or without an oral immune stimulant as a first-line treatment of feline infectious peritonitis
10.1177/1098612x251403283 · 2026 · External reference
Treatment of feline infectious peritonitis in cats with molnupiravir: Clinical observations and outcomes for 54 cases
10.1111/avj.13433 · 2025 · External reference
Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS-441524
10.1111/jvim.16803 · 2023 · External reference
Assessment of pharmacokinetics and tolerability following single-dose administration of molnupiravir in participants with hepatic or renal impairment
10.1111/cts.70073 · 2024 · External reference
Diagnosis of feline infectious peritonitis: A review of the current literature
10.3390/v11111068 · 2019 · External reference
Risk factors associated with the development of chronic kidney disease in cats evaluated at primary care veterinary hospitals
10.2460/javma.244.3.320 · 2014 · External reference
Molnupiravir: Mechanism of action, clinical, and translational science
10.1111/cts.13732 · 2024 · External reference
Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis
10.1177/1098612x19825701 · 2019 · External reference
Open label clinical trial of orally administered molnupiravir as a first-line treatment for naturally occurring effusive feline infectious peritonitis
10.1111/jvim.17187 · 2024 · External reference
Efficacy of oral remdesivir in treating feline infectious peritonitis: A prospective observational study of 29 cats
10.1177/1098612x251335189 · 2025 · External reference
Measurement of feline alpha-1 acid glycoprotein in serum and effusion using an ELISA method: Analytical validation and diagnostic role for feline infectious peritonitis
10.3390/pathogens13040289 · 2024 · External reference
Unlicensed Molnupiravir is an effective rescue treatment following failure of Unlicensed GS-441524-like therapy for cats with suspected feline infectious peritonitis
10.3390/pathogens11101209 · 2022 · External reference
Molnupiravir treatment of 18 cats with feline infectious peritonitis: A case series
10.1111/jvim.16832 · 2023 · External reference
GS-441524 and molnupiravir are similarly effective for the treatment of cats with feline infectious peritonitis
10.3389/fvets.2024.1422408 · 2024 · External reference
ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease
10.1177/1098612x16631234 · 2016 · External reference
Feline infectious peritonitis: European advisory board on cat diseases guidelines
10.3390/v15091847 · 2023 · External reference
Update on treatment of feline infectious peritonitis: European advisory board on cat diseases (ABCD) guidelines
10.3390/v18040452 · 2026 · External reference
2022 AAFP/EveryCat Feline infectious peritonitis Diagnosis guidelines
10.1177/1098612x221118761 · 2022 · External reference
Evaluation of the course of improvement with molnupiravir treatment for feline infectious peritonitis
2025 · External reference
Short treatment of 42 days with oral GS-441524 results in equal efficacy as the recommended 84-day treatment in cats suffering from feline infectious peritonitis with effusion-A prospective randomized controlled study
10.3390/v16071144 · 2024 · External reference
